Are animal models predictive for humans?

Philosophy, Ethics, and Humanities in Medicine

Volumn 4, Issue 1, 2009, Pages

  Shanks, Niall ^a   Greek, Ray ^b   Greek, Jean ^b  

^a WICHITA STATE UNIVERSITY   (United States)

^b Americans For Medical Advancement   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; FORECASTING; HUMAN; REVIEW;

ANIMAL EXPERIMENTATION; ANIMALS; FORECASTING; HUMANS; MODELS, ANIMAL;

EID: 60949086792     PISSN: None     EISSN: 17475341     Source Type: Journal    
DOI: 10.1186/1747-5341-4-2     Document Type: Review

References (87)

1. Sarewitz D Pielke RA Jr Prediction in Science and Policy Prediction: Science, Decision Making, and the Future of Nature Island Press Sarewitz D, Pielke RA Jr, Byerly R Jr 2000:11-22.
2. Quine W Quiddities" An Intermittently Philosophical Dictionary Cambridge: The Belknap Press of Harvard University Press 2005.
3. LaFollette H Shanks N Brute Science: Dilemmas of animal experimentation London and New York: Routledge 1996.
4. Greek R Greek J Specious Science New York: Continuum Int 2002.
5. Xceleron http://www.xceleron.com/metadot/index.pl
6. Altman L Who Goes First? The Story of Self-Experimentation in Medicine University of California Press 1998.
7. Bruder CE Piotrowski A Gijsbers AA Andersson R Erickson S de Stahl TD Menzel U Sandgren J von Tell D Poplawski A Crowley M Crasto C Partridge EC Tiwari H Allison DB Komorowski J van Ommen GJ Boomsma DI Pedersen NL den Dunnen JT Wirdefeldt K Dumanski JP Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles Am J Hum Genet 2008, 82:763-771. 10.1016/j.ajhg.2007.12.011 18304490
8. Fraga MF Ballestar E Paz MF Ropero S Setien F Ballestar ML Heine-Suner D Cigudosa JC Urioste M Benitez J Boix-Chornet M Sanchez-Aguilera A Ling C Carlsson E Poulsen P Vaag A Stephan Z Spector TD Wu YZ Plass C Esteller M Epigenetic differences arise during the lifetime of monozygotic twins Proc Natl Acad Sci USA 2005, 102:10604-10609. 1174919 16009939 10.1073/ pnas.0500398102
9. Weiss ST McLeod HL Flockhart DA Dolan ME Benowitz NL Johnson JA Ratain MJ Giacomini KM Creating and evaluating genetic tests predictive of drug response Nat Rev Drug Discov 2008, 7:568-574. 10.1038/nrd2520 18587383
10. Kaiser J Gender in the pharmacy: Does it matter? Science 2005, 308:1572. 10.1126/science.308.5728.1572 15947169
11. Willyard C Blue's clues Nat Med 2007, 13:1272-1273. 10.1038/nm1107-1272 17987010
12. Couzin J Cancer research. Probing the roots of race and cancer Science 2007, 315:592-594. 10.1126/science.315.5812.592 17272699
13. Holden C Sex and the suffering brain Science 2005, 308:1574. 10.1126/ science.308.5728.1574 15947170
14. Salmon W Rational Prediction Philosophy of Science Curd M, Cover J, Norton 1998:433-444.
15. Butcher EC Can cell systems biology rescue drug discovery? Nat Rev Drug Discov 2005, 4:461-467. 10.1038/nrd1754 15915152
16. Horrobin DF Modern biomedical research: An internally self-consistent universe with little contact with medical reality? Nat Rev Drug Discov 2003, 2:151-154. 10.1038/nrd1012 12563306
17. Pound P Ebrahim S Sandercock P Bracken MB Roberts I Where is the evidence that animal research benefits humans? BMJ 2004, 328:514-517. 351856 14988196 10.1136/bmj.328.7438.514
18. Ediorial The time is now Nat Rev Drug Discov 2005, 4:613. 10.1038/ nrd1817 16106580
19. Littman BH Williams SA The ultimate model organism: Progress in experimental medicine Nat Rev Drug Discov 2005, 4:631-638. 10.1038/ nrd1800 16056389
20. Uehling M Microdoses of Excitement over AMS, 'Phase 0' Trials Bio-IT World 2006, 2006:.
21. Dixit R Boelsterli U Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies Drug Discovery Today 2007, 12:336-342. 10.1016/ j.drudis.2007.02.018 17395094
22. Greek R Greek J Sacred Cows and Golden Geese: The Human Cost of Experiments on Animals New York: Continuum Int 2000.
23. Greek J Greek R What Will We Do if We Don't Experiment on Animals. Continuum 2004.
24. FDA Issues Advice to Make Earliest Stages Of Clinical Drug Development More Efficient http://www.fda.gov/bbs/topics/news/2006/NEW01296.html
25. Knight A The beginning of the end for chimpanzee experiments? Philos Ethics Humanit Med 2008, 3:16. 2432070 18518999 10.1186/1747-5341-3-16
26. Shanks N Pyles RA Evolution and medicine: The long reach of "Dr. Darwin" Philos Ethics Humanit Med 2007, 2:4. 1852567 17407602 10.1186/1747-5341-2-4
27. Vineis P Melnick R A Darwinian perspective: Right premises, questionable conclusion. A commentary on Niall Shanks and Rebecca Pyles' "evolution and medicine: The long reach of "Dr. Darwin"" Philos Ethics Humanit Med 2008, 3:6. 2265736 18269763 10.1186/1747-5341-3-6
28. Debate title: Animals are predictive for humans http://video.google.com/ videoplay?docid=-8464924004908818871&q=madison+debate+ animal&total=5&start=0&num=30&so=0&type= search&plindex=0
29. Gad S Preface Animal Models in Toxicology CRC Press Gad S 2007, 1-18.
30. Fomchenko EI Holland EC Mouse models of brain tumors and their applications in preclinical trials Clin Cancer Res 2006, 12:5288-5297. 10.1158/1078-0432.CCR-06-0438 17000661
31. Hau J Animal Models Handbook of Laboratory Animal Science Animal Models CRC Press Hau J, van Hoosier GK Jr 2 2003, II:2-8.
32. Staff Of Mice... and Humans Drug Discovery and Development 2008, 11:16-20.
33. FDA panel recommends continued use of controversial diabetes drug http://www.cnn.com/HEALTH/9903/26/rezulin.review.02/index.html
34. Masubuchi Y Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: A review Drug Metab Pharmacokinet 2006, 21:347-356. 10.2133/dmpk.21.347 17072088
35. Topol EJ Failing the public health - rofecoxib, Merck, and the FDA N Engl J Med 2004, 351:1707-1709. 10.1056/NEJMp048286 15470193
36. Heywood R Clinical Toxicity - Could it have been predicted? Post-marketing experience Animal Toxicity Studies: Their Relevance for Man Lumley CE, Walker S Lancaster, Quay 1990 57 67
37. Spriet-Pourra C Auriche M Drug Withdrawal from Sale New York 2 1994.
38. Igarashi T The duration of toxicity studies required to support repeated dosing in clinical investigation - A toxicologists opinion CMR Workshop: The Timing of Toxicological Studies to Support Clinical Trials Boston/ UK: Kluwer Parkinson CNM, Lumley C, Walker SR 1994:67-74.
39. Sankar U The Delicate Toxicity Balance in Drug Discovery The Scientist 2005, 19:32. 12535578
40. Wilbourn J Haroun L Heseltine E Kaldor J Partensky C Vainio H Response of experimental animals to human carcinogens: An analysis based upon the IARC Monographs programme Carcinogenesis 1986, 7:1853-1863. 10.1093/ carcin/7.11.1853 3769134
41. Rall DP Laboratory animal tests and human cancer Drug Metab Rev 2000, 32:119-128. 10.1081/DMR-100100565 10774768
42. Tomatis L Aitio A Wilbourn J Shuker L Human carcinogens so far identified Jpn J Cancer Res 1989, 80:795-807. 2513295
43. Knight A Bailey J Balcombe J Animal carcinogenicity studies: 1. Poor human predictivity Altern Lab Anim 2006, 34:19-27. 16522147
44. Tomatis L Wilbourn L Evaluation of carcinogenic risk to humans: The experience of IARC New Frontiers in Cancer Causation Washington, DC: Taylor and Francis Iversen 2003:371-387.
45. IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Lyon: IARC 1972.
46. IARC monographs programme on the evaluation of carcinogenic risks to humans http://monographs.iarc.fr
47. Haseman JK Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk Drug Metab Rev 2000, 32:169-186. 10.1081/DMR-100100570 10774773
48. Gold LS Slone TH Ames BN What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database Drug Metab Rev 1998, 30:359-404. 10.3109/03602539808996318 9606609
49. Freeman M St Johnston D Wherefore DMM? Disease Models & Mechanisms 2008, 1:6-7. 2561967 19048041 10.1242/dmm.000760
50. Schardein J Drugs as Teratogens CRC Press 1976.
51. Schardein J Chemically Induced Birth Defects. Marcel Dekker 1985.
52. Manson J Wise D Teratogens Casarett and Doull's Toxicology 4 1993:228.
53. Caldwell J Comparative Aspects of Detoxification in Mammals Enzymatic Basis of Detoxification New York: Academic Press Jakoby W 1980. 1
54. Runner MN Comparative pharmacology in relation to teratogenesis Fed Proc 1967, 26:1131-1136. 5339261
55. Keller SJ Smith MK Animal virus screens for potential teratogens. I. Poxvirus morphogenesis Teratog Carcinog Mutagen 1982, 2:361-374. 10.1002/ 1520-6866(1990)2:3/4<361::AID-TCM1770020318>3.0.CO;2-I 6130636
56. Staples RE Holtkamp DE Effects of Parental Thalidomide Treatment on Gestation and Fetal Development Exp Mol Pathol 1963, 26:81-106. 14089666
57. Caldwell J Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism Toxicol Lett 1992, 64-65(Spec No):651-659. 10.1016/0378-4274(92)90244-E
58. Wall RJ Shani M Are animal models as good as we think? Theriogenology 2008, 69:2-9. 10.1016/j.theriogenology.2007.09.030 17988725
59. Curry SH Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships Ann N Y Acad Sci 2003, 993:69-74. discussion 79-81 12853296
60. Shubick P Statement of the Problem Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis Ablex Pub Coulston F, Shubick P 1980:5-17.
61. Coulston F Final Discussion Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis Ablex Coulston F, Shubick P 1980:407.
62. Council_on_Scientific_Affairs Carcinogen regulation JAMA 1981, 246:253-256. 10.1001/jama.246.3.253 7241769
63. Salsburg D The lifetime feeding study in mice and rats - an examination of its validity as a bioassay for human carcinogens Fundam Appl Toxicol 1983, 3:63-67. 10.1016/S0272-0590(83)80174-2 6884625
64. IARC IARC Working group on the evaluation of carcinogenic risks to humans Lyon 1972:1-78.
65. Sloan DA Fleiszer DM Richards GK Murray D Brown RA Increased incidence of experimental colon cancer associated with long-term metronidazole therapy Am J Surg 1983, 145:66-70. 10.1016/0002-9610(83)90168-X 6295197
66. Clemmensen J Hjalgrim-Jensen S On the absence of carcinogenicity to man of phenobarbital Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis Coulston F, Shubick S Alex Pub 1980, 251-265.
67. Clayson D The carcinogenic action of drugs in man and animals Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis Ablex Pub Coulston F, Shubick P 1980:185-195.
68. Anisimov V Carcinogenesis and Aging Boca Rotan: CRC Press 1987.
69. Anisimov V Molecular and Physiological Mechanisms of Aging St Petersburg: Nauka 2003.
70. Dilman VM Anisimov VN Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice Gerontology 1980, 26:241-246. 7390164
71. IARC Some aromatic amines, hydrazine and related substances, n-nitroso compounds and miscellaneous alkylating agents IARC monograph on the evaluation of carcinogenic risks to humans, Lyon 1974, 4:
72. Anisimov VN Ukraintseva SV Yashin AI Cancer in rodents: Does it tell us about cancer in humans? Nat Rev Cancer 2005, 5:807-819. 10.1038/nrc1715 16195752
73. Hahn WC Weinberg RA Modelling the molecular circuitry of cancer Nat Rev Cancer 2002, 2:331-341. 10.1038/nrc795 12044009
74. Rangarajan A Weinberg RA Opinion: Comparative biology of mouse versus human cells: Modelling human cancer in mice Nat Rev Cancer 2003, 3:952-959. 10.1038/nrc1235 14737125
75. Anisimov VN Age as a risk in multistage carcinogenesis Comprehensive Geriatric Oncology M E: Informa Healthcare. Taylor and Francis group Balducci L, Ershler WB, Lyman GH 2 2004, 75(101):157-178.
76. Overmier JB Carroll ME Basic Issues in the Use of Animals in Health Research Animal Research and Human Health American Psychological Association Carroll ME, Overmier JB 2001:5.
77. Kolata G 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects New York Times. New York 1997.
78. Olson H Betton G Robinson D Thomas K Monro A Kolaja G Lilly P Sanders J Sipes G Bracken W Dorato M Van Deun K Smith P Berger B Heller A Concordance of the toxicity of pharmaceuticals in humans and in animals Regul Toxicol Pharmacol 2000, 32:56-67. 10.1006/rtph.2000.1399 11029269
79. Shanks N Greek R Nobis N Greek J Animals and Medicine: Do Animal Experiments Predict Human Response? Skeptic 2007, 13:44-51.
80. Conn P Parker J Letter. Animal research wars Skeptic 2007, 13:18-19.
81. Van Regenmortel MH Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism EMBO Rep 2004, 5:1016-1020. 1299179 15520799 10.1038/sj.embor.7400284
82. Morange M A successful form for reductionism The Biochemist 2001, 23:37-39.
83. Morange M The misunderstood gene Cambridge: Harvard University Press 2001.
84. Mepham TB Combes RD Balls M Barbieri O Blokhuis HJ Costa P Crilly RE de Cock Buning T Delpire VC O'Hare MJ Houdebine LM van Kreijl CF Meer van der M Reinhardt CA Wolf E van Zeller AM The Use of Transgenic Animals in the European Union: The Report and Recommendations of ECVAM Workshop 28 Altern Lab Anim 1998, 26:21-43. 11656813
85. Liu Z Maas K Aune TM Comparison of differentially expressed genes in T lymphocytes between human autoimmune disease and murine models of autoimmune disease Clin Immunol 2004, 112:225-230. 10.1016/ j.clim.2004.03.017 15308114
86. Dennis C Cancer: Off by a whisker Nature 2006, 442:739-741. 10.1038/ 442739a 16915261
87. Houdebine LM Transgenic animal models in biomedical research Methods Mol Biol 2007, 360:163-202. 17172731